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Ninety physicians practicing in the state of Virginia USA completed a mail survey regarding Multiple Chemical Sensitivity (MCS).
Survey questions addressed demographics; familiarity with MCS; etiology; overlapping conditions; accommodations made for
patients and practices regarding evaluation, treatment, and referral. A little over half of respondents were familiar with MCS.
Underathirdhadreceived anymedicaltrainingregardingchemicalsensitivity,only7%were“verysatisﬁed”withtheirknowledge,
and 6% had a treatment protocol for the condition. Participants cited a range of etiologies and overlapping conditions including
asthma, Reactive Airway Dysfunction Syndrome (RADS), Sick Building Syndrome (SBS), Chronic Fatigues Syndrome (CFS), and
Fibromyalgia. Physicians infrequently considered chemicals as a cause of illness when seeing new patients. Evaluation techniques
included interviews, blood work, immune proﬁles, and allergy testing. Interventions recommended included chemical avoidance,
alterations in the home environment, diet restrictions, the use of air ﬁlters, and referrals to outside specialists.
1.Introduction
Persons who experience Multiple Chemical Sensitivity
(MCS),alsoreferredtoaschemicalintolerance,environmen-
tal illness, and chemical hypersensitivity [1], are a medically
underserved group making up 12.6% of the US population
[2], with 4% experiencing the symptoms daily [3]. The
condition has been studied in a number of other countries as
well, including Japan [4, 5], Germany [6], Sweden [7, 8], and
TheNetherlands[9].AndinCanada2.4%ofCanadiansaged
12 and over have been diagnosed with MCS [10]. Individuals
withMCSreportexperiencingdisablingsymptomsasaresult
of low-level exposures to chemicals in ambient air generally
tolerated by a majority of the population. The need for
chemicalavoidancelimitstheiraccesstoenvironmentswhere
suchexposuresmightoccur,suchaslibraries,medicaloﬃces,
grocery stores, community meetings, and places of worship
[11]. Though the diagnosis of Multiple Chemical Sensitivity
hasbeenthesubjectofadetailedreportcommissionedbythe
Canadian Human Rights Commission [12], the condition
continues to be surrounded by medical controversy and
uncertainty regarding its label, causes, and indicated treat-
ments. Unlike chronic fatigue (myalgic encephalomyelitis
or ME in the UK), which now receives some recognition
and study from the medical profession, MCS remains a
marginalized condition in mainstream medical practice and
patients report mixed experiences when requesting medical
help.
McColl et al. found that persons with disabilities in gen-
eral had three times the unmet medical needs of nondisabled
people and that disabled respondents with unmet needs had
seenanincreasednumberofproviders,butstillperceivedthe
system to be inadequate [13]. Because physicians are often
unfamiliar with and/or do not believe in MCS and because
their oﬃces may contain chemical barriers, individuals
often receive inadequate medical attention. Patients report
experiencing considerable iatrogenic harm due to unmet
medical needs, delays in correct diagnosis, or treatment for
the wrong condition [14]. Gibson et al. found that patients
experimented with between 24 and 37 diﬀerent treatments,
thusspendingconsiderabletimeandmoneyoninterventions
that may or may not be helpful [15]. To date, only one
researcher has studied physicians’ views regarding MCS [16].
The purpose of the current study was to examine practicing
physicians’ current views and practices relating to multiple
chemical sensitivities.2 ISRN Nursing
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Figure 1: Physicians’ views regarding etiology of MCS.
2. Method
After receiving approval from our university Institutional
Review Board, we mailed a survey that included informed
consent to a random sample of 1000 US physicians licensed
and practicing in the state of Virginia. Questions included
information about the participants’ medical specialty, prac-
tice setting, and other demographics; any training or edu-
cation received regarding chemical sensitivity; amount of
experience with patients reporting sensitivities; degree of
and satisfaction with knowledge regarding MCS; personal
beliefs about the causes and appropriate treatments for the
condition; treatment protocols; and referral practices. One
reminder was sent.
3. Results
3.1. Demographics and Training. Participants included 90
physicians licensed and practicing in Virginia with a mean of
15.5 years in practice. Overall, 26 specialties were included;
most commonly represented were family practice and inter-
nal medicine. Other specialties included gynecology, emer-
gency medicine/urgent care, anesthesiology, diagnostic radi-
ology, ophthalmology, dermatology, general surgery, podi-
atry, otolaryngology, occupational/environmental medicine,
cardiology, pediatrics, orthopedics, physical medicine and
rehabilitation, rheumatology, medical acupuncture, geri-
atrics, oral and maxiofacial surgery, neonatology, pulmonary
medicine, urology, pathology, nephrology, and oncology.
Physicians reported having seen a median of 3 patients
with chemical sensitivities in the past year and 10 over the
course of their careers. When asked how familiar they were
withMCS,9%responded“veryunfamiliar,”36%“somewhat
unfamiliar,” 48% “somewhat familiar,” and 8% “very famil-
iar.”PhysiciansreportedgainingknowledgeaboutMCSfrom
a variety of sources, including other health providers (51%),
journal articles (47%), formal education/medical school
(30%), the media (16%), mentors/experts (13%), profes-
sionalconferences(9%),andbooks(4%).Respondentsrated
their level of satisfaction with their current knowledge of
MCS as “not at all satisﬁed” (35%), “somewhat satisﬁed”
(59%), or “very satisﬁed” (7%).
3.2. Physicians Perceptions. When asked whether they
believed chemical sensitivity to be a medical or psychological
condition, over half saw it as a combination, and there was a
slightskew towards physiologicaletiology asseen in Figure 1.
No respondents endorsed a purely psychological etiology.
However, physicians’ beliefs varied regarding the causes of
MCS. When asked to select which commonly theorized
causes played a role in the development of MCS, almost
all respondents selected all the options given. “Multiple
low level chemical exposures over time” was selected most
often, endorsed by 90% of physicians. “One large chemical
exposure” and “genetics” were each endorsed by approxi-
mately three quarters of respondents, as were “psychological
factors,” “stress,” and “elevated risk perception.”
In those who have already developed MCS, physi-
cians often saw gender (51%), geographic location (41%),
educational level (40%), and socioeconomic status (41%)
as inﬂuencing the development of the condition. Fewer
respondents considered age (31%) and race (21%) to be
inﬂuencing factors.
Physicians also listed dozens of conditions that they
believed overlap with MCS. The most commonly listed
were asthma (91%), Reactive Airway Dysfunction Syndrome
(79%), Sick Building Syndrome (71%), Chronic Fatigue
Syndrome(62%),andﬁbromyalgia(60%).Inanopen-ended
section, physicians listed dozens of other conditions, includ-
ing allergy, rash/dermatitis, rhinitis, headaches/migraines,
Lyme disease, irritable bowel syndrome, lupus, autism,
and autoimmune disorders. Psychological factors were also
noted, including depression, generalized anxiety, posttrau-
matic stress disorder, and hopelessness.
3.3. Physicians’ Practices. The majority (87%) of physicians
reported only rarely or sometimes considering chemicals as
the cause of a patient’s illness, and only 6% reported having
a deﬁned treatment protocol for this population. The only
evaluation procedure used by more than half of respondents
was the patient interview. See Figure 2 f o ro t h e re v a l u a t i o n
techniques used.
After determining that a patient was experiencing sen-
sitivity to chemicals, some physicians reported making
accommodations for the patient within their oﬃce. Forty-
two percent reported refraining from using fragrances or
problematic personal care products when visiting with the
sensitive patient, and 21% reported lessening the use of
chemical cleaners within the oﬃce space. Only 15% alerted
patients to chemical changes in the oﬃce environment. Few
reported meeting in a safer location for the patient (12%) or
making home visits (2%).ISRN Nursing 3
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Figure 2: Evaluation techniques used by physicians for patients with MCS.
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Figure 3: Interventions suggested by physicians for patients with MCS.
Speciﬁc interventions recommended by physicians in-
cluded chemical avoidance (82%), alterations in the home
environment (64%), diet restrictions (49%), or air puriﬁers
in the home (46%). Twenty percent commonly referred
patientsforpsychiatricevaluationorcounseling.SeeFigure3
for other interventions suggested. Some physicians treated
patients themselves, but also made referrals to outside
specialists (see Figure 4). Most commonly these referrals
wereto allergists,ENT specialists, and pulmonary specialists.
4. Conclusions
Though 97% of respondents in this study have had patients
reporting chemical sensitivities, only 6% had a treatment
protocol for this condition. With prevalence of MCS at
approximately 13% of the US population [2] and patients
reporting accessing a mean of eight physicians each over the
course of their illness [1] it is clear that there is a need for
informed medical help for people with chemical sensitivities.
Unfortunately, only 30% of physicians in this sample had
received any training regarding MCS in medical school.
And given that only 13% reported frequently considering
chemicals when diagnosing health problems in new patients,
missed cases of MCS may result in incorrect treatment and
possible iatrogenic harm.
People with MCS may lose employment due to sen-
sitivities and have a need for Social Security Disability
Income (SSDI). Yet, 49% of respondents indicated that
they were unlikely to accept a patient applying for worker’s
compensation or SSDI. Similarly, 62% were unlikely to
accept a patient involved in accommodation-related job
litigation.
McColl et al. report that the barriers to receiving
treatment for persons with disabilities include the physical
layout of the practice and its barriers, health care providers’
attitudes toward disability, providers’ expertise regarding
theirdisability,andothersystemicfactors[13].Inadditionto
these barriers, persons with MCS face the chemical barriers
that are common in commercial settings, including chemical
cleaners, pesticides, fragrance on medical personnel, and
other exposures that may require mitigation in order for per-
sons to gain medical access. Fortunately, some respondents
made accommodations for persons with MCS to visit their
oﬃces.
Respondents made referrals to a large number of spe-
cialists, highlighting the need for education about MCS
across medical specialties. Research into the development
of eﬀective treatment protocols is necessary in order for
patientswithMCStoreceivewellthoughtoutcare.Giventhe
controversyregardingMCSetiology,itisuncertainwhattype
of training physicians in this study received. However, it is
important that health practitioners in training attend to the
growing body of research on physiological mechanisms for
MCS and not simply dismiss the condition as psychogenic.4 ISRN Nursing
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Figure 4: Outside referrals made by physicians for patients with MCS.
In addition, given that a high percentage of people with
MCS attribute the onset of their illness to chemical exposure,
there is a need for greater understanding of the toxic eﬀects
of chemicals in ambient air. It is of concern that physicians
only infrequently considered chemicals as a source of illness.
Henry called for nurses and physicians to attend to pesticide-
induced illness over 15 years ago [17], and physicians have
long called for attention to conditions caused by chemical
exposure [18, 19]. Some attention to toxicology would not
only include those with sensitivity syndromes in mainstream
medical care, but would move toward acknowledging the
contribution of toxics to common conditions such as asthma
and cancer that are still not well understood [19].
Nursing researchers have addressed the issue of MCS
[20–24], thus educating nursing personnel regarding the
characteristics and needs of this population. Nurses can
assist with providing accommodations, designing treatment
protocols, and conducting research on this under-addressed
condition. Doing so will aid in making health care provision
more inclusive for persons who have been underserved
and denied necessary health care and assistance in living.
Accessible oﬃces, educated health care providers, and will-
ingness to assist with disability applications and community-
based accommodations would address crucial needs and
reduce suﬀering and obstacles in the lives of persons with
environmental sensitivities.
This study suﬀers from a low response rate, yet the rate
may be an indication of the position of MCS in mainstream
medicine, that is, it may be that responders are actually
those with the most open attitudes toward the condition.
For example, one nonrespondent sent us a note back with
an empty survey that read, “Don’t waste my time any more.”
And the Virginia State Medical Association refused to allow
us to hand out surveys at their annual meeting because our
research was “not consistent” with the goals of their meeting.
Despite this resistance, results are useful for examining how
physicians who do recognize and address MCS treat the
condition and to whom they make referrals. This base of
responsive physicians should be increased in order to track
and improve access, prevention, and medical treatments
available to persons with MCS [10]. The spreading phe-
nomenon associated with MCS dictates that patients may
have a tendency to worsen in the absence of intervention.
To allow a contested illness to continue to deteriorate the
lives of those who experience it without making eﬀorts to
understand, prevent, and treat the condition is irresponsible.
Yet MCS remains on the margins, creating a struggle for
survival and access in those who experience it.
Conﬂict of Interests
Theauthorshavenoconﬂictofinterestsregardingthispaper.
Acknowledgments
The authors acknowledge receiving a faculty research grant
from the College of Integrated Sciences and Technology
at James Madison University to complete this research.
They thank Jessica Merkel and Natalie Marston for their
help in early phases of this study. Portions of this paper
were delivered at the International Association for Chronic
Fatigue Syndrome (IACFS) 8th International Conference on
Chronic Fatigue Syndrome, Fibromyalgia and other Related
Illnesses, January 12–14, 2007. BahiaMarBeach Resort, Ft.
Lauderdale, Florida, USA.
References
[1] P. R. Gibson, J. Cheavens, and M. L. Warren, “Multiple
chemicalsensitivity/environmentalillnessandlifedisruption,”
Women & Therapy, vol. 19, pp. 63–79, 1996.
[2] S. M. Caress and A. C. Steinemann, “A review of a two-
phase population study of multiple chemical sensitives,”
Environmental Health Perspectives, vol. 111, no. 12, pp. 1490–
1497, 2003.
[3] W. J. Meggs, K. A. Dunn, R. M. Bloch, P. E. Goodman, and
A. L. Davidoﬀ, “Prevalence and nature of allergy and chemical
sensitivity in a general population,” Archives of Environmental
Health, vol. 51, no. 4, pp. 275–282, 1996.ISRN Nursing 5
[4] S. Hojo, S. Ishikawa, H. Kumano, M. Miyata, and K. Sakabe,
“Clinical characteristics of physician-diagnosed patients with
multiplechemicalsensitivityinJapan,”InternationalJournalof
Hygiene and Environmental Health, vol. 211, no. 5-6, pp. 682–
689, 2007.
[5] S. Ishikawa and M. Miyata, “Chemical sensitivity and its
clinicalcharacteristicsinJapan,”AsianMedicalJournal,vol.43,
no. 1, pp. 7–15, 2003.
[6] C. Hausteiner, S. Bornschein, J. Hansen, T. Zilker, and H.
F¨ orstl, “Self-reported chemical sensitivity in Germany: a
population-basedsurvey,”InternationalJournalofHygieneand
Environmental Health, vol. 208, no. 4, pp. 271–278, 2005.
[7] L. Andersson, A. Johansson, E. Millqvist, S. Nordin, and M.
Bende, “Prevalence and risk factors for chemical sensitivity
and sensory hyperreactivity in teenagers,” International Jour-
nal of Hygiene and Environmental Health, vol. 211, no. 5-6, pp.
690–697, 2008.
[8] ˚ A. Johansson, ˚ A. Br¨ amerson, E. Millqvist, S. Nordin, and M.
Bende, “Prevalence and risk factors for self-reported odour
intolerance:theSk¨ ovdepopulation-basedstudy,”International
ArchivesofOccupationalandEnvironmentalHealth,vol.78,no.
7, pp. 559–564, 2005.
[9] N. D. Berg, A. Linneberg, A. Dirksen, and J. Elberling,
“Prevalence of self-reported symptoms and consequences
related to inhalation of airborne chemicals in a Danish
general population,” International Archives of Occupational
and Environmental Health, vol. 81, no. 7, pp. 881–887, 2008.
[ 1 0 ]M .R .L a v e r g n e ,D .C .C o l e ,K .K e r r ,a n dL .M .M a r -
shall, “Functional impairment in chronic fatigue syndrome,
ﬁbromyalgia, and multiple chemical sensitivity,” Canadian
Family Physician, vol. 56, no. 2, pp. e57–e65, 2010.
[11] P. R. Gibson, “Of the world but not in it: barriers to com-
munity access and education for persons with environmental
sensitivities,” Health Care for Women International, vol. 31, no.
1, pp. 3–16, 2010.
[12] M. E. Sears, The Medical Perspective on Environmental Sensi-
tivities, Canadian Human Rights Commission, 2007.
[13] M. A. McColl, A. Jarzynowska, and S. E. D. Shortt, “Unmet
health care needs of people with disabilities: population level
evidence,” Disability & Society, vol. 25, no. 2, pp. 205–218,
2010.
[14] L. R. Engel, P. R. Gibson, M. E. Adler, and V. M. Rice,
“Unmet medical needs in persons with self-reported multiple
chemical sensitivity,” in Proceedings of the Annual Meeting of
the Southeastern Psychological Association, Norfolk, Va, USA,
March 1996.
[15] P. R. Gibson, A. N. M. Elms, and L. A. Ruding, “Perceived
treatment eﬃcacy for conventional and alternative therapies
reported by persons with multiple chemical sensitivity,”
Environmental Health Perspectives, vol. 111, no. 12, pp. 1498–
1504, 2003.
[16] K. M. Rest, “A survey of AOEC physician practices and
attitudes regarding multiple chemical sensitivity,” Toxicology
and Industrial Health, vol. 8, no. 4, pp. 51–66, 2002.
[17] T. K. Henry, “Pesticide exposure seen in primary care,” Nurse
Practitioner Forum, vol. 8, no. 2, pp. 50–58, 1995.
[18] T. Schettler, “Changing patterns of disease: human health and
the environment,” San Francisco Medicine,v o l .7 5 ,n o .9 ,p p .
11–13, 2002.
[19] G.M.Solomon,“Rareandcommondiseasesinenvironmental
health,”SanFranciscoMedicine,vol.75,no.9,pp.14–16,2002.
[20] P. R. Gibson, “Social support and attitude toward health
care delivery as predictors of hope in persons with multiple
chemical sensitivity,” Journal of Clinical Nursing, vol. 8, no. 3,
pp. 275–283, 1999.
[21] P.R.Gibson,J.Cheavens,andM.L.Warren,“Socialsupportin
persons with self-reported sensitivity to chemicals,” Research
in Nursing & Health, vol. 21, no. 2, pp. 103–115, 1998.
[22] P. R. Gibson and V. M. Vogel, “Sickness-related dysfunction
in persons with self-reported multiple chemical sensitivity at
four levels of severity,” Journal of Clinical Nursing, vol. 18, no.
1, pp. 72–81, 2009.
[23] N. Imai, Y. Imai, and Y. Kido, “Psychosocial factors that
aggravate the symptoms of sick house syndrome in Japan,”
Nursing and Health Sciences, vol. 10, no. 2, pp. 101–109, 2008.
[24] C. Larsson and L. M˚ artensson, “Experiences of problems in
individuals with hypersensitivity to odours and chemicals,”
Journal of Clinical Nursing, vol. 18, no. 5, pp. 737–744, 2009.